Image Processing Pipeline to Compute Homologous Recombination Score-Reference-Cited by-同舟云学术

Image Processing Pipeline to Compute Homologous Recombination Score

Published:2022-04-20 Issue: Volume: Page:
ISSN:
Container-title:Proceedings of the 12th International Conference on Biomedical Engineering and Technology
language:
Short-container-title:

Author:

Vundavilli Haswanth¹,Tumiati Manuela²,Hautaniemi Sampsa²,Datta Aniruddha³,Kauppi Liisa²

Affiliation:

1. Texas A&M University, USA and The University of Texas MD Anderson Cancer Center, USA

2. Research Program in Systems Oncology, Faculty of Medicine, University of Helsinki, Finland

3. Department of Electrical and Computer Engineering & The Center for Bioinformatics and Genomic Systems Engineering, Texas A&M University, USA

Funder

NSF (National Science Foundation)

Academy of Finland

European Union's Horizon 2020

TEES-AgriLife Center for Bioinformatics and Genomic Systems Engineering (CBGSE)

Publisher

ACM

Link

https://dl.acm.org/doi/pdf/10.1145/3535694.3535704

Reference12 articles.

1. Platinum compounds: a hope for future cancer chemotherapy;Ali I., A;Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry-Anti-Cancer Agents),2013

2. Fuchs R.P. 2002. How DNA lesions are turned into mutations within cells?. Oncogene 21(58). Fuchs R.P. 2002. How DNA lesions are turned into mutations within cells?. Oncogene 21(58).

3. da Cunha Colombo Bonadio , R.R. , Fogace , R.N. , Miranda , V.C. and Diz , M.D.P . E ., 2018 . Homologous recombination deficiency in ovarian cancer: a review of its epidemiology and management. Clinics , 73. da Cunha Colombo Bonadio, R.R., Fogace, R.N., Miranda, V.C. and Diz, M.D.P.E., 2018. Homologous recombination deficiency in ovarian cancer: a review of its epidemiology and management. Clinics, 73.

4. Wiedemeyer W.R. Beach J.A. and Karlan B.Y. 2014. Reversing platinum resistance in high-grade serous ovarian carcinoma: targeting BRCA and the homologous recombination system. Frontiers in oncology 4 p.34. Wiedemeyer W.R. Beach J.A. and Karlan B.Y. 2014. Reversing platinum resistance in high-grade serous ovarian carcinoma: targeting BRCA and the homologous recombination system. Frontiers in oncology 4 p.34.

5. Telli M.L. Timms K.M. Reid J. Hennessy B. Mills G.B. Jensen K.C. Szallasi Z. Barry W.T. Winer E.P. Tung N.M. and Isakoff S.J. 2016. Homologous recombination deficiency (HRD) score predicts response to platinum-containing neoadjuvant chemotherapy in patients with triple-negative breast cancer. Clinical cancer research 22(15) pp.3764-3773. Telli M.L. Timms K.M. Reid J. Hennessy B. Mills G.B. Jensen K.C. Szallasi Z. Barry W.T. Winer E.P. Tung N.M. and Isakoff S.J. 2016. Homologous recombination deficiency (HRD) score predicts response to platinum-containing neoadjuvant chemotherapy in patients with triple-negative breast cancer. Clinical cancer research 22(15) pp.3764-3773.